Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Jun'25
Jun'24
Jun'23
Jun'22
Jun'21
Jun'20
Jun'19
Net Sales
13,153.52
12,409.24
12,396.98
9,779.88
5,795.40
3,527.62
2,607.03
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
13,153.52
12,409.24
12,396.98
9,779.88
5,795.40
3,527.62
2,607.03
Raw Material Cost
11,236.87
10,912.16
10,955.79
8,484.16
5,052.55
3,112.81
2,291.44
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
631.27
553.42
453.83
340.48
248.65
169.26
145.10
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
323.63
299.91
140.55
64.19
40.78
43.92
18.46
Selling and Distribution Expenses
381.88
358.09
320.71
356.47
198.64
171.80
185.30
Other Expenses
-95.21
-85.33
-58.47
-39.37
-28.94
-21.32
-16.36
Total Expenditure (Excl Depreciation)
11,621.54
11,270.25
11,286.17
8,851.60
5,251.18
3,284.61
2,476.74
Operating Profit (PBDIT) excl Other Income
1532
1139
1110.8
928.3
544.2
243
130.29999999999998
Other Income
173.21
438.47
23.58
221.63
4.82
7.47
4.77
Operating Profit (PBDIT)
1,846.22
1,686.75
1,206.12
1,206.08
606.21
298.74
178.81
Interest
323.63
299.91
140.55
64.19
40.78
43.92
18.46
Exceptional Items
0.00
29.28
-19.26
-4.48
0.00
0.00
0.00
Gross Profit (PBDT)
1,916.65
1,497.08
1,441.19
1,295.72
742.86
414.81
315.59
Depreciation
168.09
138.22
90.59
76.83
65.69
52.29
46.08
Profit Before Tax
1,354.51
1,277.91
955.72
1,060.58
499.75
202.53
114.26
Tax
462.47
444.44
297.74
406.88
147.98
59.11
86.46
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
892.04
833.46
657.98
653.69
351.77
143.42
27.80
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
892.04
833.46
657.98
653.69
351.77
143.42
27.80
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
892.04
833.46
657.98
653.69
351.77
143.42
27.80
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10.0
10.0
10.0
10.0
10.0
100.0
100.0
Reserves
10,867.58
5,633.13
5,373.07
4,713.98
4,366.05
978.31
837.75
Earnings per share (EPS)
3.9
3.65
2.88
2.88
2.15
28.97
5.62
Diluted Earnings per share
3.9
3.65
2.88
2.88
2.15
28.97
5.62
Operating Profit Margin (Excl OI)
11.44%
8.95%
8.81%
9.28%
9.24%
6.77%
4.91%
Gross Profit Margin
11.58%
11.41%
8.44%
11.63%
9.76%
7.22%
6.15%
PAT Margin
6.78%
6.72%
5.31%
6.68%
6.07%
4.07%
1.07%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Jun 2025 is 6.00% vs 0.10% in Jun 2024
Consolidate Net Profit
YoY Growth in year ended Jun 2025 is 7.02% vs 26.67% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Jun 2025 is 34.02% vs 5.56% in Jun 2024
Interest
YoY Growth in year ended Jun 2025 is 7.90% vs 113.45% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Jun 2025 has improved from Jun 2024
Compare Annual Results Of Citi Pharma Ltd. With
Figures in Million
Consolidate Annual Results
Change(PKR)
Change(%)
Net Sales
13,153.52
18,856.90
-5,703.38
-30.25%
Other Operating Income
0.00
0.00
0.00
Total Operating income
13,153.52
18,856.90
-5,703.38
-30.25%
Raw Material Cost
11,236.87
11,228.60
8.27
0.07%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
631.27
3,390.38
-2,759.11
-81.38%
Power Cost
0
0
0.00
Manufacturing Expenses
323.63
568.46
-244.83
-43.07%
Selling and Distribution Expenses
381.88
5,638.38
-5,256.50
-93.23%
Other Expenses
-95.21
-395.88
300.67
75.95%
Total Expenditure (Excl Depreciation)
11,621.54
16,866.98
-5,245.44
-31.10%
Operating Profit (PBDIT) excl Other Income
1,531.98
1,989.92
-457.94
-23.01%
Other Income
173.21
164.35
8.86
5.39%
Operating Profit (PBDIT)
1,846.22
3,017.74
-1,171.52
-38.82%
Interest
323.63
568.46
-244.83
-43.07%
Exceptional Items
0.00
10.06
-10.06
-100.00%
Gross Profit (PBDT)
1,916.65
7,628.30
-5,711.65
-74.87%
Depreciation
168.09
934.14
-766.05
-82.01%
Profit Before Tax
1,354.51
1,525.19
-170.68
-11.19%
Tax
462.47
603.48
-141.01
-23.37%
Provisions and contingencies
0
0
0.00
Profit After Tax
892.04
776.54
115.50
14.87%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
892.04
776.54
115.50
14.87%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
145.17
-145.17
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
892.04
921.71
-29.67
-3.22%
Equity Capital
0
0
0.00
Face Value
10.00
10.00
0.00
Reserves
10,867.58
12,375.20
-1,507.62
-12.18%
Earnings per share (EPS)
3.90
17.86
-13.96
-78.16%
Diluted Earnings per share
3.90
17.86
-13.96
-78.16%
Operating Profit Margin (Excl OI)
11.44%
10.18%
0.00
1.26%
Gross Profit Margin
11.58%
13.04%
0.00
-1.46%
PAT Margin
6.78%
4.12%
0.00
2.66%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 1,315.35 Million
in Jun 2025Figures in Million
YoY Growth in year ended Jun 2025 is 6.00% vs 0.10% in Jun 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 89.20 Million
in Jun 2025Figures in Million
YoY Growth in year ended Jun 2025 is 7.02% vs 26.67% in Jun 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 167.30 Million
in Jun 2025Figures in Million
YoY Growth in year ended Jun 2025 is 34.02% vs 5.56% in Jun 2024
Annual - Interest
Interest 32.36 Million
in Jun 2025Figures in Million
YoY Growth in year ended Jun 2025 is 7.90% vs 113.45% in Jun 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.44%
in Jun 2025Figures in %
YoY Growth in year ended Jun 2025 has improved from Jun 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
